Bernardo L. Rapoport

The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

Jean Klášterský, Marianne Paesmans, Edward Rubenstein et al. · Journal of Clinical Oncology · 2000 · 1.2K citations

Medicine, Health Sciences, Oncology +15

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Timothy J. Littlewood, Emilio Bajetta, J.W.R. Nortier et al. · Journal of Clinical Oncology · 2001 · 977 citations

Medicine, Hematology, Pharmacology +13

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

Jean Klášterský, Julien de Naurois, K. V. I. Rolston et al. · Annals of Oncology · 2016 · 750 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +8

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

Fausto Roila, Alex Molassiotis, Jørn Herrstedt et al. · Annals of Oncology · 2016 · 580 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12